Strategy, Enterprise and Innovation: A Case Study on Pfizer

Strategy, Enterprise
and Innovation

Table of Contents
INTRODUCTION...........................................................................................................................1
MAIN BODY...................................................................................................................................1
Appropriate frameworks and any appropriate tools to identify and evaluate the key drivers of
innovation contributing to the success of Pfizer.....................................................................1
Strategy frameworks to critically analyse the different approaches undertaken by Pfizer to
help shape its entrepreneurial vision and business model......................................................5
Evaluate the statement into critical manner “Pfizer’s success can be attributed to the
successful application of the “Blue ocean strategy”. Apply the proper blue ocean frameworks
and tools such as value curves and strategy canvas to compare Pfizer and its competitors
which is based on the success factors for the industry which is critical in terms of nature........8
CONCLUSION..............................................................................................................................10
REFERENCES..............................................................................................................................12

INTRODUCTION
Strategy enterprise and innovation refers to the skills to develop to develop ideas which
strengthen organisation from entrepreneurial start-ups to national governments and also helps
them in growing it. An effective strategy innovation basically clarifies about the goals and
priorities but the strategy of innovation basically outlines about the goals of an organisation
innovation activities. They also help in terms of focusing on reaching towards the goals. In the
present report, a case study is taken into consideration which is named as Pfizer. This case study
is about the research based global biopharmaceutical company which is headquartered in New
York. The company is specialised into chemical compounds which included an anti parasitic
product called santonin. The company has collaborated themselves with governments, health
care providers and local communities in order to support and epand the access to reliable, health
care affordable on the world wide basis. The present report will cover discussion about the key
drivers of innovation which contributes to the success of Pfizer and also about different
approaches which is undertaken by Pfizer in order to help shape their business model and
entrepreneurial vision as well. Moreover, the report will cover analysis about the critical
evaluation of statement with support of blue ocean strategy.
MAIN BODY
Appropriate frameworks and any appropriate tools to identify and evaluate the key drivers of
innovation contributing to the success of Pfizer
With the help of PESTLE analysis the key drivers of innovation can be identified that have
contributed to the success of Pfizer. The PESTLE analysis is a framework that is helpful in
identifying and understanding the external environmental factors that affect the business
activities and leads to changes (Chepsarakov, 2022). With the help of PESTLE analysis the
external environment factors that affect the activities of the organisation can be evaluated and
understood easily. The PESTLE analysis of Pfizer is given below.
 Political factors: It includes the effect of changing political conditions such as trade
restrictions, international relations, quota barriers etc. that directly or indirectly affects the
activities of the business. Pfizer the organisation operates in a global market and has a
1

major impact on its activities due to the regulation by the political or government forces
across different nations. Countries across the world are constantly facing uncertainty in
their political environment that creates complexity to the abilities of the company to
operate smoothly in various countries. The government is responsible for creating
pharmaceutical policies and regulations in their countries that affect the overall activities
of the organisation and its innovation strategies in a given country. For instance, the US
and UK adopted nationalist agenda in 2016-17 that aroused variation in political
conditions and led to the lack of clarity in relation to the legal and regulatory Health care
reforms. Pfizer tries to engage in the policy making, government decisions and regulatory
frameworks for active engagement to anticipate better political understanding and
suitability for performing their business activities effectively and efficiently.
 Economic conditions: It can be explained as the economic factors such as the changing
demographic conditions, employment, taxation, currency exchange etc. that affects the
activities of business. The aging and changing demographic conditions throughout the
world have led to increased pressure on the health care institutions. The changing
economic conditions such as the increasing or rising prices across the global economy,
high level of competition, healthcare budgets etc. are reducing the chances of the
organisation to have better impacts on providing good health care and enhance healthcare
activities for the people. Pfizer is trying to invest in medicine delivery that is cost
effective and increases the quality of life for the people. The company tries to provide
medicines and services that are reasonably affordable for the patients, government and
payers, to create better values of the organisation.
 Social factors: This can be explained as the social behaviour or community aspects in
which the people reside that affects their lifestyle as well as the activities of the
organisation (Deng, You and Wang, 2019). Changing patient demographics and their
lifestyle such as urbanization, health habits, diet planning or food, prevalence of non-
communicable diseases, occurrence of catastrophic diseases etc. are major causes that are
impacting the innovation activities of the organisation for enhancing its success. The
diseases like cancer, cardiovascular failure, diabetes, obesity and the occurrence of highly
communicable diseases such as Covid-19 have affected and created a need for medical
and pharmaceutical organisations to innovate and develop new breakthrough medicine
2